CNTN
Canton Strategic Holdings Inc.

3,046
Mkt Cap
$193.3M
Volume
726,026.00
52W High
$9.08
52W Low
$0.952
PE Ratio
-1.25
CNTN Fundamentals
Price
$4.71
Prev Close
$4.89
Open
$4.80
50D MA
$3.46
Beta
0.73
Avg. Volume
1.06M
EPS (Annual)
-$9.41
P/B
5.73
Rev/Employee
$0.00
$0.9279
Loading...
Loading...

About

Canton Strategic Holdings, Inc. is a clinical-stage biotechnology company developing a portfolio of therapeutic candidates for inflammation and immunology. It also develops TH104, which is known to suppress chronic, debilitating pruritus or uncontrollable itching in PBC, a rare and orphan liver disease with no known cure. The company was founded on March 28, 2017 and is headquartered in Bridgewater, NJ.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
2

Frequently Asked Questions

What is Market Cap of Canton Strategic Holdings Inc.?
What is the 52-week high for Canton Strategic Holdings Inc.?
What is the 52-week low for Canton Strategic Holdings Inc.?
What is Canton Strategic Holdings Inc. stock price today?
What was Canton Strategic Holdings Inc. stock price yesterday?
What is the PE ratio of Canton Strategic Holdings Inc.?
What is the Price-to-Book ratio of Canton Strategic Holdings Inc.?
What is the 50-day moving average of Canton Strategic Holdings Inc.?
How many employees does Canton Strategic Holdings Inc. have?

Latest CNTN News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.